Pricing

Log inSign up

Palatin Technologies

0 followers

‌

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.

Industries

Biotechnology, Pharmaceutical

Headquarters

Cranbury, United States

Employees

51-200

Links

Org chart

CS
Carl Spana
CEO, President & Director
Collapse
Stephen T. Wills
COO, CFO, Treasurer & Secretary
Stephen A. Slusher
Chief Legal Officer
Michael B. Raizman
Chief Medical Officer
Paul Kayne
VP, Biological Sciences
JW
J. Don Wang
VP, Product Development
Don Wang
Vice President, Prod Dev (CMC)
JL
Johna Lucas
Chief Medical Officer
James E. Hattersley
SVP, Business Development
MS
Milin Shah
Quality Manager
Alka Kamra
Senior Manager Regulatory Affairs

Board & advisors

JP
John K.A. Prendergast
Founder & Chairman
Alan W. Dunton
Director
AM
Anthony M. Manning
Director
Arlene M. Morris
Director
Rd
Robert K. deVeer
Director
SH
Stanley Hull
Director
JH
J. Stanley Hull
Director

Teams

CS
+6

Leadership Team

10 people · 0 jobs

+2

Research and Development

6 people · 0 jobs

Clinical Operations and Regulatory Affairs

3 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Xeris Pharmaceuticals

2 followers

AbbVie

269 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Amgen

273 followers

Elanco

26 followers

Eikon Therapeutics

3 followers

Cosette Pharmaceuticals

1 follower

Bristol-Myers Squibb

250 followers

Explore companies